Free Trial

Cypress Asset Management Inc. TX Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Cypress Asset Management Inc. TX purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 10,158 shares of the healthcare conglomerate's stock, valued at approximately $5,240,000. UnitedHealth Group accounts for approximately 1.3% of Cypress Asset Management Inc. TX's holdings, making the stock its 23rd largest holding.

A number of other large investors have also recently bought and sold shares of UNH. Capital & Planning LLC grew its holdings in UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after acquiring an additional 79 shares during the period. Brighton Jones LLC increased its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Financial Partners Group LLC lifted its stake in shares of UnitedHealth Group by 0.5% during the fourth quarter. Financial Partners Group LLC now owns 8,055 shares of the healthcare conglomerate's stock valued at $4,074,000 after buying an additional 42 shares during the period. MFA Wealth Services acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $512,000. Finally, Motive Wealth Advisors grew its holdings in UnitedHealth Group by 17.1% in the 4th quarter. Motive Wealth Advisors now owns 755 shares of the healthcare conglomerate's stock valued at $382,000 after buying an additional 110 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the business's stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by insiders.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Morgan Stanley dropped their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. KeyCorp cut their target price on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Truist Financial restated a "buy" rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Wolfe Research dropped their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $441.87.

View Our Latest Analysis on UNH

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $1.15 during trading hours on Thursday, hitting $296.97. The stock had a trading volume of 10,351,888 shares, compared to its average volume of 6,724,002. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $269.39 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 1.37 and a beta of 0.56. The stock's fifty day simple moving average is $439.50 and its 200 day simple moving average is $498.65.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the company posted $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
The Hottest AI Stock You Haven’t Bought Yet

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines